← Back to Search

Observational (survey, medical records review) for Blood Cancers

N/A
Waitlist Available
Led By Sumanta K Pal
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights

Summary

This study collects information about perception of cure among patients with cancer that has spread to other places in the body (metastatic). This study aims to determine patients' perception (knowledge) before starting immunotherapy and if differences exist in understanding of treatment to stimulate or restore the ability of the body's immune (defense) system to fight infection and disease (immunotherapy) based on social and economic factors or on race/ethnicity.

Eligible Conditions
  • Blood Cancers
  • Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Functional Assessment of Cancer Therapy-General (FACT-G)
Patient Reported Outcomes Measurement Information System (PROMIS)
Percentage of patients
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Observational (survey, medical records review)Experimental Treatment2 Interventions
Patients complete surveys over 30 minutes about sociodemographic information and perception of immunotherapy, over 10 minutes about expectations of cure, over 10 minutes about anxiety, over 10 minutes about depression, and over 30 minutes about physical well-being. Patients' medical records are reviewed.

Find a Location

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor
589 Previous Clinical Trials
1,923,399 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,789 Previous Clinical Trials
40,986,295 Total Patients Enrolled
2 Trials studying Blood Cancers
110 Patients Enrolled for Blood Cancers
Sumanta K PalPrincipal InvestigatorCity of Hope Medical Center
9 Previous Clinical Trials
353 Total Patients Enrolled
~0 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top